麻酔薬の世界市場 2024年～2028年

麻酔薬市場は2023年～2028年年に14億4,490万米ドル、予測期間中のCAGRは4.36％で成長すると予測されます。

当レポートでは、麻酔薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、がんの有病率の上昇、手術件数の増加、高齢者人口の増加が牽引しています。

本調査では、今後数年間の麻酔薬市場成長を牽引する主な要因の1つとして、全身麻酔に代わる麻酔の採用が増加していることを挙げています。また、製品上市の増加やヘルスケアインフラの急速な拡大も、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023年
• 市場の見通し 2023年～2028年

第4章 市場規模実績

• 麻酔薬の世界市場 2018年～2022年
• タイプセグメント分析 2018年～2022年
• 投与経路セグメント分析 2018年～2022年
• 地域別セグメント分析 2018年～2022年
• 国別セグメント分析 2018年～2022年

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメンテーション
• 比較：タイプ別
• 全身麻酔：市場規模と予測 2023年～2028年
• 局所麻酔と区域麻酔：市場規模と予測 2023年～2028年
• 市場機会：タイプ別

第7章 市場セグメンテーション：投与経路別

• 市場セグメンテーション
• 比較：投与経路別
• 静脈内：市場規模と予測 2023年～2028年
• 吸入：市場規模と予測 2023年～2028年
• その他：市場規模と予測 2023年～2028年
• 市場機会：投与経路別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023年～2028年
• 欧州：市場規模と予測 2023年～2028年
• アジア：市場規模と予測 2023年～2028年
• 世界のその他の地域：市場規模と予測 2023年～2028年
• 米国：市場規模と予測 2023年～2028年
• ドイツ：市場規模と予測 2023年～2028年
• 英国：市場規模と予測 2023年～2028年
• 中国：市場規模と予測 2023年～2028年
• インド：市場規模と予測 2023年～2028年
• 市場機会：地域情勢別

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• AbbVie Inc.
• AstraZeneca Plc
• Avet Pharmaceuticals Inc.
• Baxter International Inc.
• B.Braun SE
• Eisai Co. Ltd.
• Fresenius SE and Co. KGaA
• Glenmark Pharmaceuticals Ltd.
• Hikma Pharmaceuticals Plc
• Maruishi Pharmaceutical Co. Ltd.
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Piramal Enterprises Ltd.
• Septodont Holding

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Anesthesia Drugs Market 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on Type - Market share 2023-2028 (%)
• Exhibits33: Data Table on Type - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by Type
• Exhibits35: Data Table on Comparison by Type
• Exhibits36: Chart on General anesthesia - Market size and forecast 2023-2028 ($ million)
• Exhibits37: Data Table on General anesthesia - Market size and forecast 2023-2028 ($ million)
• Exhibits38: Chart on General anesthesia - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on General anesthesia - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on Local and regional anesthesia - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Data Table on Local and regional anesthesia - Market size and forecast 2023-2028 ($ million)
• Exhibits42: Chart on Local and regional anesthesia - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Local and regional anesthesia - Year-over-year growth 2023-2028 (%)
• Exhibits44: Market opportunity by Type ($ million)
• Exhibits45: Data Table on Market opportunity by Type ($ million)
• Exhibits46: Chart on Route of Administration - Market share 2023-2028 (%)
• Exhibits47: Data Table on Route of Administration - Market share 2023-2028 (%)
• Exhibits48: Chart on Comparison by Route of Administration
• Exhibits49: Data Table on Comparison by Route of Administration
• Exhibits50: Chart on Intravenous - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Data Table on Intravenous - Market size and forecast 2023-2028 ($ million)
• Exhibits52: Chart on Intravenous - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
• Exhibits54: Chart on Inhalational - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Data Table on Inhalational - Market size and forecast 2023-2028 ($ million)
• Exhibits56: Chart on Inhalational - Year-over-year growth 2023-2028 (%)
• Exhibits57: Data Table on Inhalational - Year-over-year growth 2023-2028 (%)
• Exhibits58: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits59: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits60: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits61: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits62: Market opportunity by Route of Administration ($ million)
• Exhibits63: Data Table on Market opportunity by Route of Administration ($ million)
• Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits67: Chart on Geographic comparison
• Exhibits68: Data Table on Geographic comparison
• Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits101: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibits102: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibits103: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibits104: Data Table on India - Year-over-year growth 2023-2028 (%)
• Exhibits105: Market opportunity By Geographical Landscape ($ million)
• Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits107: Impact of drivers and challenges in 2023 and 2028
• Exhibits108: Overview on criticality of inputs and factors of differentiation
• Exhibits109: Overview on factors of disruption
• Exhibits110: Impact of key risks on business
• Exhibits111: Companies covered
• Exhibits112: Matrix on companies position and classification
• Exhibits113: AbbVie Inc. - Overview
• Exhibits114: AbbVie Inc. - Product / Service
• Exhibits115: AbbVie Inc. - Key news
• Exhibits116: AbbVie Inc. - Key offerings
• Exhibits117: AstraZeneca Plc - Overview
• Exhibits118: AstraZeneca Plc - Product / Service
• Exhibits119: AstraZeneca Plc - Key news
• Exhibits120: AstraZeneca Plc - Key offerings
• Exhibits121: Avet Pharmaceuticals Inc. - Overview
• Exhibits122: Avet Pharmaceuticals Inc. - Product / Service
• Exhibits123: Avet Pharmaceuticals Inc. - Key offerings
• Exhibits124: Baxter International Inc. - Overview
• Exhibits125: Baxter International Inc. - Business segments
• Exhibits126: Baxter International Inc. - Key news
• Exhibits127: Baxter International Inc. - Key offerings
• Exhibits128: Baxter International Inc. - Segment focus
• Exhibits129: B.Braun SE - Overview
• Exhibits130: B.Braun SE - Business segments
• Exhibits131: B.Braun SE - Key news
• Exhibits132: B.Braun SE - Key offerings
• Exhibits133: B.Braun SE - Segment focus
• Exhibits134: Eisai Co. Ltd. - Overview
• Exhibits135: Eisai Co. Ltd. - Business segments
• Exhibits136: Eisai Co. Ltd. - Key offerings
• Exhibits137: Eisai Co. Ltd. - Segment focus
• Exhibits138: Fresenius SE and Co. KGaA - Overview
• Exhibits139: Fresenius SE and Co. KGaA - Business segments
• Exhibits140: Fresenius SE and Co. KGaA - Key news
• Exhibits141: Fresenius SE and Co. KGaA - Key offerings
• Exhibits142: Fresenius SE and Co. KGaA - Segment focus
• Exhibits143: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibits144: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibits145: Glenmark Pharmaceuticals Ltd. - Key news
• Exhibits146: Glenmark Pharmaceuticals Ltd. - Key offerings
• Exhibits147: Hikma Pharmaceuticals Plc - Overview
• Exhibits148: Hikma Pharmaceuticals Plc - Business segments
• Exhibits149: Hikma Pharmaceuticals Plc - Key news
• Exhibits150: Hikma Pharmaceuticals Plc - Key offerings
• Exhibits151: Hikma Pharmaceuticals Plc - Segment focus
• Exhibits152: Maruishi Pharmaceutical Co. Ltd. - Overview
• Exhibits153: Maruishi Pharmaceutical Co. Ltd. - Product / Service
• Exhibits154: Maruishi Pharmaceutical Co. Ltd. - Key offerings
• Exhibits155: Merck and Co. Inc. - Overview
• Exhibits156: Merck and Co. Inc. - Business segments
• Exhibits157: Merck and Co. Inc. - Key news
• Exhibits158: Merck and Co. Inc. - Key offerings
• Exhibits159: Merck and Co. Inc. - Segment focus
• Exhibits160: Novartis AG - Overview
• Exhibits161: Novartis AG - Business segments
• Exhibits162: Novartis AG - Key news
• Exhibits163: Novartis AG - Key offerings
• Exhibits164: Novartis AG - Segment focus
• Exhibits165: Pfizer Inc. - Overview
• Exhibits166: Pfizer Inc. - Product / Service
• Exhibits167: Pfizer Inc. - Key news
• Exhibits168: Pfizer Inc. - Key offerings
• Exhibits169: Piramal Enterprises Ltd. - Overview
• Exhibits170: Piramal Enterprises Ltd. - Product / Service
• Exhibits171: Piramal Enterprises Ltd. - Key offerings
• Exhibits172: Septodont Holding - Overview
• Exhibits173: Septodont Holding - Product / Service
• Exhibits174: Septodont Holding - Key offerings
• Exhibits175: Inclusions checklist
• Exhibits176: Exclusions checklist
• Exhibits177: Currency conversion rates for US$
• Exhibits178: Research methodology
• Exhibits179: Information sources
• Exhibits180: Data validation
• Exhibits181: Validation techniques employed for market sizing
• Exhibits182: Data synthesis
• Exhibits183: 360 degree market analysis
• Exhibits184: List of abbreviations

The anesthesia drugs market is forecasted to grow by USD 1444.9 mn during 2023-2028, accelerating at a CAGR of 4.36% during the forecast period. The report on the anesthesia drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cancer, increasing number of surgeries, and rising elderly population.

Technavio's anesthesia drugs market is segmented as below:

By Type

• General anesthesia
• Local and regional anesthesia

By Route Of Administration

• Intravenous
• Inhalational
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing adoption of alternatives to general anesthesia as one of the prime reasons driving the anesthesia drugs market growth during the next few years. Also, increasing number of product launches and rapidly expanding healthcare infrastructure will lead to sizable demand in the market.

The report on the anesthesia drugs market covers the following areas:

• Anesthesia drugs market sizing
• Anesthesia drugs market forecast
• Anesthesia drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anesthesia drugs market vendors that include AbbVie Inc., Aspen Pharmacare Holdings Ltd., AstraZeneca Plc, Avet Pharmaceuticals Inc., Baxter International Inc., B.Braun SE, Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Endo International Plc, Fresenius SE and Co. KGaA, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Maruishi Pharmaceutical Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Piramal Enterprises Ltd., Septodont Holding, and Troikaa Pharmaceuticals Ltd.. Also, the anesthesia drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Anesthesia Drugs Market 2018 - 2022
  • Historic Market Size - Data Table on Global Anesthesia Drugs Market 2018 - 2022 ($ million)
• 4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Route of Administration segment analysis 2018 - 2022
  • Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 6.3 General anesthesia - Market size and forecast 2023-2028
  • Chart on General anesthesia - Market size and forecast 2023-2028 ($ million)
  • Data Table on General anesthesia - Market size and forecast 2023-2028 ($ million)
  • Chart on General anesthesia - Year-over-year growth 2023-2028 (%)
  • Data Table on General anesthesia - Year-over-year growth 2023-2028 (%)
• 6.4 Local and regional anesthesia - Market size and forecast 2023-2028
  • Chart on Local and regional anesthesia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Local and regional anesthesia - Market size and forecast 2023-2028 ($ million)
  • Chart on Local and regional anesthesia - Year-over-year growth 2023-2028 (%)
  • Data Table on Local and regional anesthesia - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Route of Administration

• 7.1 Market segments
  • Chart on Route of Administration - Market share 2023-2028 (%)
  • Data Table on Route of Administration - Market share 2023-2028 (%)
• 7.2 Comparison by Route of Administration
  • Chart on Comparison by Route of Administration
  • Data Table on Comparison by Route of Administration
• 7.3 Intravenous - Market size and forecast 2023-2028
  • Chart on Intravenous - Market size and forecast 2023-2028 ($ million)
  • Data Table on Intravenous - Market size and forecast 2023-2028 ($ million)
  • Chart on Intravenous - Year-over-year growth 2023-2028 (%)
  • Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
• 7.4 Inhalational - Market size and forecast 2023-2028
  • Chart on Inhalational - Market size and forecast 2023-2028 ($ million)
  • Data Table on Inhalational - Market size and forecast 2023-2028 ($ million)
  • Chart on Inhalational - Year-over-year growth 2023-2028 (%)
  • Data Table on Inhalational - Year-over-year growth 2023-2028 (%)
• 7.5 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)
  • Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
• 12.4 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
• 12.5 Avet Pharmaceuticals Inc.
  • Avet Pharmaceuticals Inc. - Overview
  • Avet Pharmaceuticals Inc. - Product / Service
  • Avet Pharmaceuticals Inc. - Key offerings
• 12.6 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
• 12.7 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Business segments
  • B.Braun SE - Key news
  • B.Braun SE - Key offerings
  • B.Braun SE - Segment focus
• 12.8 Eisai Co. Ltd.
  • Eisai Co. Ltd. - Overview
  • Eisai Co. Ltd. - Business segments
  • Eisai Co. Ltd. - Key offerings
  • Eisai Co. Ltd. - Segment focus
• 12.9 Fresenius SE and Co. KGaA
  • Fresenius SE and Co. KGaA - Overview
  • Fresenius SE and Co. KGaA - Business segments
  • Fresenius SE and Co. KGaA - Key news
  • Fresenius SE and Co. KGaA - Key offerings
  • Fresenius SE and Co. KGaA - Segment focus
• 12.10 Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd. - Overview
  • Glenmark Pharmaceuticals Ltd. - Product / Service
  • Glenmark Pharmaceuticals Ltd. - Key news
  • Glenmark Pharmaceuticals Ltd. - Key offerings
• 12.11 Hikma Pharmaceuticals Plc
  • Hikma Pharmaceuticals Plc - Overview
  • Hikma Pharmaceuticals Plc - Business segments
  • Hikma Pharmaceuticals Plc - Key news
  • Hikma Pharmaceuticals Plc - Key offerings
  • Hikma Pharmaceuticals Plc - Segment focus
• 12.12 Maruishi Pharmaceutical Co. Ltd.
  • Maruishi Pharmaceutical Co. Ltd. - Overview
  • Maruishi Pharmaceutical Co. Ltd. - Product / Service
  • Maruishi Pharmaceutical Co. Ltd. - Key offerings
• 12.13 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
• 12.14 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
• 12.15 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
• 12.16 Piramal Enterprises Ltd.
  • Piramal Enterprises Ltd. - Overview
  • Piramal Enterprises Ltd. - Product / Service
  • Piramal Enterprises Ltd. - Key offerings
• 12.17 Septodont Holding
  • Septodont Holding - Overview
  • Septodont Holding - Product / Service
  • Septodont Holding - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations